KARA DRAVENSTOTT: Open Payments
NPI 1386095586 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,017 in 102 payments from 26 companies in 2025. Trend: 2023 $2,173 · 2024 $2,086 · 2025 $2,017
Food & beverage: $2,017
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $355 |
| Amgen Inc. | 15 | $258 |
| AstraZeneca Pharmaceuticals LP | 12 | $229 |
| Novartis Pharmaceuticals Corporation | 7 | $161 |
| Novo Nordisk Inc | 6 | $143 |
| UCB, Inc. | 5 | $96 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Janssen Biotech, Inc. | 3 | $68 |
| Organon LLC | 3 | $67 |
| PFIZER INC. | 3 | $61 |
Products named: SKYRIZI, SAPHNELO, COSENTYX, Ozempic, Bimzelx, AIRSUPRA, KRYSTEXXA, RINVOQ.
Industry payments across WV — which companies pay providers there.
